OINDRILA BANIK

Ms. OINDRILA BANIK

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in IEEE Transactions on Nanobioscience
Verified
Journal Article
Closed access
SAShaik Ahmadsaidulu
Shaik Ahmadsaidulu
OBOINDRILA BANIK
OINDRILA BANIK
PKPrasoon Kumar
Prasoon Kumar
Santosh KumarSantosh Kumar
Santosh Kumar
EBEaru Banoth
Earu Banoth
The lifestyle of modern society is a major contributing factor for the majority of patients suffering from more than one disease. To Screen and diagnose each of those diseases, there is a great need for portable, and economical diagnostic tools, which are highly stipulated to yield rapid and accurate results using a small volume of the samples such as blood, saliva, sweat, etc. Point-of-care Testing (POCT) is one of the approaches to harvest prompt diagnosis of numerous diseases. The Majority of Point-of-Care Devices (POCD) are developed to diagnose one disease within the specimen. On the other hand, multi-disease detection capabilities in the same point-of-care devices are considered to be an efficient candidate to execute the state-of-the-art platform for multi-disease detection. Most of the literature reviews in this field focus on Point-of-Care (POC) devices, their underlying principles of operation, and their potential applications. It is evident from a perusal of the scholarly works that no review articles have been written on multi-disease detection PoC devices. A review study analyzing the current level and functionality of multi-disease detection POC devices would be of great use to future researchers and device manufacturers. This review paper is addressing the above gap by focusing on various optical techniques like fluorescence, Absorbance, and Surface Plasmon Resonance (SPR) for multi-disease detection by harnessing the microfluidic-based POC device.

23 October 2024 in Nanotechnology
Verified
Journal Article
Closed access
OBOINDRILA BANIK
OINDRILA BANIK
ASAmol Lalchand Salve
Amol Lalchand Salve
PKPrasoon Kumar
Prasoon Kumar
Santosh KumarSantosh Kumar
Santosh Kumar
EBEaru Banoth
Earu Banoth
In recent years, significant advancements in nanotechnology have improved the various disciplines of scientific fields. Nanomaterials, like, carbon-based (carbon nanotubes, graphene), metallic, metal oxides, conductive polymers, and 2D materials (MXenes) exhibit exceptional electrical conductivity, mechanical strength, flexibility, thermal property and chemical stability. These materials hold significant capability in transforming material science and biomedical engineering by enabling the creation of more efficient, miniaturized, and versatile devices. The indulgence of nanotechnology with conductive materials in biological fields promises a transformative innovation across various industries, from bioelectronics to environmental regulations. The conductivity of nanomaterials with a suitable size and shape exhibits unique characteristics, which provides a platform for realization in bioelectronics as biosensors, tissue engineering, wound healing, and drug delivery systems. It can be explored for state-of-the-art cardiac, skeletal, nerve, and bone scaffold fabrication while highlighting their proof-of-concept in the development of biosensing probes and medical imaging. This review paper highlights the significance and application of the conductive nanomaterials associated with conductivity and their contribution towards a new perspective in improving the healthcare system globally.

8 January 2025 in IEEE Transactions on Nanobioscience
Verified
Journal Article
Closed access
OBOINDRILA BANIK
OINDRILA BANIK
BBBansod Sneha Bharat
Bansod Sneha Bharat
ABAnju R. Babu
Anju R. Babu
PKPrasoon Kumar
Prasoon Kumar
Santosh KumarSantosh Kumar
Santosh Kumar
EBEaru Banoth
Earu Banoth
Eggshell (ES) wastes have been ranked as the $15^{\text {th}}$ food industry pollution due to the ever-increasing regular consumption of primary dietary products, eggs. Management and treatment of tons of discarded eggshells produced daily on a global scale are realized to be a predicament, and an immediate solution must be advocated to address the pollution. This sets a tone for the recyclability of this biowaste in a myriad of fields, like nanotechnology, biomedical, and environmental pollution control. Calcium carbonate in the shells makes it a safe precursor for producing calcium oxide as a nanomaterial by the top-down approach – calcination. This paper highlights a facile way to procure waste eggshell-derived metal oxide nanoparticles with reproducibility and recyclability. Calcium Oxide Nanoparticles (CaO NPs) obtained at two different calcination temperatures for optimization and this was characterized by SEM, FTIR, XRD, DLS, and Zeta Potential analyzer. CaONPs are less-studied metal oxide nanoparticles but hold promising applications in different fields. Hence, there is a scope for further investigation on the non-toxic, non-hazardous CaO NPs obtained facilely – an effort to minimize and regulate food wastes.

26 April 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YZYitian Zhang
Yitian Zhang
GLGabriel Linaje-Ferrel
Gabriel Linaje-Ferrel
JAJuan Manuel Rocha Angel
Juan Manuel Rocha Angel
OBOINDRILA BANIK
OINDRILA BANIK
EBEaru Banoth
Earu Banoth
APAyyappasamy Sudalaiyadum Perumal
Ayyappasamy Sudalaiyadum Perumal
Lipid nanoparticles (LNPs) have become the cornerstone of nucleic acid delivery platforms, particularly in RNA-based vaccines and therapeutics. However, the conventional methods of LNP production, which are primarily reliant on microfluidic mixing of aqueous and organic solvent phases, pose limitations in terms of mRNA stability, residual organic contamination, scalability, cost, and environmental impact. These limitations prompted a renewed search for non-conventional strategies with the promise of improving mRNA-LNP encapsulation approaches. These emerging approaches aim to address key bottlenecks, including mRNA hydrolysis-driven degradation, high production losses, and complex downstream purification. Moreover, the ability to decouple LNP synthesis from mRNA encapsulation could enable streamlined, modular manufacturing workflows and customizable payload delivery, including single- or multiple-mRNA payloads, thereby expanding the therapeutic scope of LNPs. This review offers an early insight into the design principles and scalability potential of emerging non-conventional LNP encapsulation approaches, including solvent-free and microfluidics-free methodologies, and pre-built LNP workflows. We also examine trends in emerging LNP encapsulation tools, including high-shear mixing, sonication, membrane contraction, and other approaches. Finally, we extrapolate the suitability of the methods for scale-up approaches and their economic implications based on the process information.

16 April 2026 in IEEE Sensors Journal
Verified
Journal Article
Closed access
ACAbhishek Chaurasia
Abhishek Chaurasia
HKHimanshu Kumar
Himanshu Kumar
OBOINDRILA BANIK
OINDRILA BANIK
APAyyappasamy Sudalaiyadum Perumal
Ayyappasamy Sudalaiyadum Perumal
SGSivaramakrishnan Ganesan
Sivaramakrishnan Ganesan
EBEaru Banoth
Earu Banoth
Saliva-based detection is emerging as one of the most promising non-invasive biosensing platforms for disease diagnosis, particularly for glucose monitoring in diabetes management. As diabetes continues to affect millions worldwide, its burden is disproportionately higher among socioeconomically disadvantaged populations, where access to traditional blood-based diagnostics is often limited. Current self-monitoring practices typically involve finger-prick blood sampling, a method that is both painful and inconvenient, discouraging frequent testing. In contrast, salivary glucose biosensing platforms offer a painless, affordable, and accessible alternative, particularly suited to a resource-limited setting. Glucose present in saliva serves as a key biomarker, providing a convenient medium for monitoring and sensing this chronic condition. This review examines the correlation between salivary and blood glucose levels, with a particular focus on the physiological time lag between them, which can affect the accuracy of real-time biosensing. We evaluate current devices and biosensor technologies designed for salivary glucose detection, focusing on their working principles, detection ranges, sensitivities, and associated engineering and clinical challenges. Additionally, recent innovations such as enzyme-based biosensors and portable diagnostic kits are discussed for their potential to transform diabetes care and enhance healthcare accessibility across diverse populations.

1 January 2022
Verified
Conference Paper
Closed access
PDF file
PMPabitraa Madhurima
Pabitraa Madhurima
SAShaik Ahmadsaidulu
Shaik Ahmadsaidulu
OBOINDRILA BANIK
OINDRILA BANIK
EBEaru Banoth
Earu Banoth
Models derived from the latter, such as spheroids or organoids are more similar to the in-vivo environment and thus should be considered for drug testing. When entwined with a microfluidic platform imply powerful assay advantages like control media flow, minute cell, and reagents requisition during the culture. In this work, the novel approach is to cultivate healthy and diseased organoids in the same microfluidic platform through a controlled microvalve. Design and simulation are performed using AUTOCAD, CLEWIN, and COMSOL. The novel micropillar microfluidic device was fabricated using photolithography followed by soft lithography. The fabricated device is temporarily bonded to a glass slide through the double tape to check the fluid flow. The phenomenon is visualized by subjecting a solution of methylene blue across the device.